Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ: ASBP · Real-Time Price · USD
0.9133
+0.0033 (0.36%)
At close: Mar 27, 2026, 4:00 PM EDT
0.8900
-0.0233 (-2.55%)
After-hours: Mar 27, 2026, 7:56 PM EDT
Aspire Biopharma Holdings Market Cap
Aspire Biopharma Holdings has a market cap or net worth of $4.59 million as of March 27, 2026. Its market cap has decreased by -99.96% in one year.
Market Cap
4.59M
Enterprise Value
11.27M
1-Year Change
-99.96%
Ranking
Category
Stock Price
$0.91
Market Cap Chart
Since April 11, 2022, Aspire Biopharma Holdings's market cap has decreased from $349.65M to $4.59M, a decrease of -98.69%. That is a compound annual growth rate of -66.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 4.59M | -67.63% |
| Dec 31, 2025 | 14.18M | -84.12% |
| Dec 18, 2024 | 89.30M | -8.80% |
| Dec 29, 2023 | 97.91M | -73.55% |
| Dec 30, 2022 | 370.16M | 5.86% |
| Apr 11, 2022 | 349.65M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Moolec Science | 5.04M |
| Pulmatrix | 4.97M |
| Bio Green Med Solution | 4.90M |
| Quince Therapeutics | 4.88M |
| Mustang Bio | 4.87M |
| Dermata Therapeutics | 4.75M |
| Silo Pharma | 4.53M |
| Akari Therapeutics, | 4.51M |